Kelly Michael Aaron bought NEO
June 1, 2026 · Form 4 insider transaction
Kelly Michael Aaron bought 23,077 shares of NeoGenomics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
23,077
Price
$0.00
Total value
N/A
InsiderKelly Michael Aaron
Role—
CompanyNeoGenomics, Inc. (NEO)
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJune 1, 2026
Filing dateJune 3, 2026
Shares owned after67,086
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Reflects release of restricted stock units that were previously reported on a Form 4.